Dare Bioscience, Inc. Common Stock (DARE) is a publicly traded Healthcare sector company. As of July 27, 2026, DARE trades at $1.28 with a market cap of $19.17M and a P/E ratio of -1.07. DARE moved +1.59% today. Year to date, DARE is -34.69%; over the trailing twelve months it is -51.33%. Its 52-week range spans $1.16 to $9.19. Analyst consensus is buy with an average price target of $10.00. Rallies surfaces DARE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Dare Bioscience, Inc. Common Stock (DARE) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. DARE moved +1.59% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $1.28 |
| Market Cap | $19.17M |
| P/E Ratio | -1.07 |
| EPS | $-1.20 |
| Dividend Yield | 0.00% |
| 52-Week High | $9.19 |
| 52-Week Low | $1.16 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $1.03M |
| Net Income | $-13.40M |
| Gross Margin | 71.29% |
2 analysts cover DARE: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $10.00.